Search Results - "Furniss, Anna L."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    A WIC-Based Behavior Change Intervention for Postpartum Women With Overweight and Obesity: A Pilot Feasibility Randomized Trial by Thompson, Darcy A., Haemer, Matthew A., Krebs, Nancy F., Pereira, Rocio I., Moss, Angela, Furniss, Anna L., Bonczynski, Jill, Nicklas, Jacinda M.

    Published in Health promotion practice (01-07-2024)
    “…Background. Postpartum weight retention is a risk factor for obesity and is particularly important among Hispanic women who have an increased rate of obesity…”
    Get full text
    Journal Article
  2. 2

    Up to 7 Years of Sustained Weight Loss for Weight-Loss Program Completers by Mitchell, Nia S., MD, MPH, Polsky, Sarit, MD, MPH, Catenacci, Victoria A., MD, Furniss, Anna L., MS, Prochazka, Allan V., MD, MSc

    Published in American journal of preventive medicine (01-08-2015)
    “…Introduction Two issues remain elusive in weight management programs: significant, long-term weight-loss maintenance and widely accessible programs that…”
    Get full text
    Journal Article
  3. 3

    Text Message Support for Weight Loss in Patients With Prediabetes: A Randomized Clinical Trial by Fischer, Henry H, Fischer, Ilana P, Pereira, Rocio I, Furniss, Anna L, Rozwadowski, Jeanne M, Moore, Susan L, Durfee, Michael J, Raghunath, Silvia G, Tsai, Adam G, Havranek, Edward P

    Published in Diabetes care (01-08-2016)
    “…Although the benefits of in-person Diabetes Prevention Program (DPP) classes for diabetes prevention have been demonstrated in trials, effectiveness in…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Factors Associated with Achievement of Clinically Significant Weight Loss by Women in a National Nonprofit Weight Loss Program by Mitchell, Nia S, Furniss, Anna L, Helmkamp, Laura J, Van Pelt, Rachael E

    “…Clinically significant weight loss (CSWL) is ≥5% of initial weight. The purpose of the study is to determine factors associated with women achieving CSWL in…”
    Get more information
    Journal Article
  7. 7

    Elevated serum osteoprotegerin is associated with increased left ventricular mass index and myocardial stiffness by Kamimura, Daisuke, Suzuki, Takeki, Furniss, Anna L, Griswold, Michael E, Kullo, Iftikhar J, Lindsey, Merry L, Winniford, Michael D, Butler, Kenneth R, Mosley, Thomas H, Hall, Michael E

    “…Osteoprotegerin (OPG) is associated with a poor prognosis in patients with heart failure with preserved ejection fraction (HFpEF). OPG has also been associated…”
    Get full text
    Journal Article
  8. 8